Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy

OBJECTIVE: The aim of this study is to determine the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease 2019 (COVID-19) among adult patients treated with biologic agents or small molecules for chronic inflammatory rheumatic diseases, in particular for chronic inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: Quartuccio, Luca, Valent, Francesca, Pasut, Enrico, Tascini, Carlo, De Vita, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS on behalf of Société française de rhumatologie. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239017/
https://www.ncbi.nlm.nih.gov/pubmed/32445935
http://dx.doi.org/10.1016/j.jbspin.2020.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239017/
https://www.ncbi.nlm.nih.gov/pubmed/32445935
http://dx.doi.org/10.1016/j.jbspin.2020.05.003

Ejemplares similares